ViiV Healthcare secures FDA approval for Tivicay PD to treat HIV in children
ViiV Healthcare, a GSK company focused on HIV treatment, has received the US Food and Drug Administration (FDA) approval for Tivicay PD (dolutegravir) tablets for, in combination with